Alexandra M. Hanretty, PharmD*

home / authors / alexandra-m-hanretty-pharmd

Articles

Site Logo

The Continued Search for Optimal Daptomycin Dosing Strategies in VRE Bloodstream Infections

Alexandra M. Hanretty, PharmD*;Rachel V. Marini, PharmD*
August 12th 2019

Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.

Read More

Site Logo

Antimicrobial Stewardship in HAP / VAP: A Focus on Duration of Therapy

Alexandra M. Hanretty, PharmD*;Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS
August 16th 2017

Reducing overall antibiotic exposure is likely to have an impact on decreasing antimicrobial resistance.

Read More

Latest Updated Articles

Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Published: August 27th 2024 | Updated: August 28th 2024
Concerns Over Mosquito-Borne Illness Causes Massachusetts Town to Create Curfew for Parks, Spraying in Counties
Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention
Published: July 15th 2025 | Updated: July 18th 2025
Merck’s MK-8527 Advances to Phase 3 for Once-Monthly HIV Prevention
TAXIS Pharmaceuticals Earns FDA QIDP Designation for Its Efflux Pump Inhibitor for Pneumonia
Published: July 15th 2025 | Updated: July 18th 2025
TAXIS Pharmaceuticals Earns FDA QIDP Designation for Its Efflux Pump Inhibitor for Pneumonia
Study Results Find AMR Policy Messaging Misses the Mark With Agricultural Stakeholders
Published: July 15th 2025 | Updated: July 18th 2025
Study Results Find AMR Policy Messaging Misses the Mark With Agricultural Stakeholders
FDA Approves Prefilled Syringe Presentation of GSK’s Shingrix for Shingles Prevention
Published: July 17th 2025 | Updated: July 18th 2025
FDA Approves Prefilled Syringe Presentation of GSK’s Shingrix for Shingles Prevention
Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing
Published: July 15th 2025 | Updated: July 18th 2025
Findings From Screening Study for Hepatitis B and Hepatitis D Demonstrate Need for Follow-Up Testing
© 2025 MJH Life Sciences

All rights reserved.